MedTrace Logo

Compassion and Metacognition in Schizotypal Personality

NCT04764708 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2022-06-21

No results posted yet for this study

Summary

The purpose of this study is to assess the safety and efficacy of a newly developed psychotherapy for schizotypal personality disorder. This new form of psychotherapy integrates compassion focused therapy and metacognitively oriented psychotherapy.

Conditions

  • Schizotypal Personality Disorder

Interventions

BEHAVIORAL

Compassion and Metacognition Based Therapy

The intervention is a Third Wave Cognitive Therapy targeting metacognitive dysfuctions (through Metacognitively Oriented Psychotherapy) and self-criticism (through Compassion Focused Therapy).

BEHAVIORAL

Cognitive Behavioral Therapy

Standard Cognitive Behavioral Therapy for Personality Disorders plus Standard Psychopharmacological Treatment.

Sponsors & Collaborators

  • Tages Onlus

    lead OTHER

Principal Investigators

  • Simone Cheli · Tages Onlus

  • Gil Goldzweig · The Academic College of Tel-Aviv Yaffo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-15
Primary Completion
2021-09-30
Completion
2021-12-20

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04764708 on ClinicalTrials.gov